Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental Limits on Solar Reflected Dark Matter with a New Approach on Accelerated-Dark-Matter-Electron Analysis in Semiconductors.

Physical review letters·2024
Same author

Constraints on Sub-GeV Dark Matter-Electron Scattering from the CDEX-10 Experiment.

Physical review letters·2022
Same author

Exotic Dark Matter Search with the CDEX-10 Experiment at China's Jinping Underground Laboratory.

Physical review letters·2022
Same author

[A protein complex recognition method based on spatial-temporal graph convolution neural network].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2022
Same author

Effects of dietary crude protein concentration on animal performance and nitrogen utilisation efficiency at different stages of lactation in Holstein-Friesian dairy cows.

Animal : an international journal of animal bioscience·2022
Same author

[Effect of underdilated stent on the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation].

Zhonghua nei ke za zhi·2022

Related Experiment Video

Updated: May 27, 2026

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
08:14

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Published on: May 4, 2017

Cancer cell proliferation is inhibited by specific modulation frequencies.

J W Zimmerman1, M J Pennison, I Brezovich

  • 1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, 1802 6th Avenue South, NP 2566, Birmingham, AL 35294-3300, USA.

British Journal of Cancer
|December 3, 2011
PubMed
Summary

Specific electromagnetic field frequencies selectively inhibit cancer cell growth, offering a new therapeutic mechanism. This approach targets hepatocellular carcinoma (HCC) and breast cancer cells without harming normal cells, revealing a novel cancer treatment pathway.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Experiment Videos

Last Updated: May 27, 2026

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
08:14

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Published on: May 4, 2017

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Area of Science:

  • Oncology
  • Biophysics
  • Cell Biology

Background:

  • Clinical studies suggest therapeutic effects of low-level amplitude-modulated electromagnetic fields in cancer patients.
  • The underlying mechanism for the anti-proliferative effect of these fields remains largely unknown.

Purpose of the Study:

  • To elucidate the mechanism behind the anti-proliferative effects of specific electromagnetic field frequencies on cancer cells.
  • To investigate the impact of tumor-specific modulation frequencies on hepatocellular carcinoma (HCC) and breast cancer cells in vitro.

Main Methods:

  • Hepatocellular carcinoma (HCC) and breast cancer cells were exposed to 27.12 MHz radiofrequency electromagnetic fields in vitro.
  • Tumor-specific modulation frequencies identified via biofeedback were used, alongside control frequencies.
  • Cell proliferation and molecular markers were analyzed to assess treatment efficacy.

Main Results:

  • HCC-specific and breast cancer-specific modulation frequencies significantly reduced the proliferation of their respective cancer cells.
  • Nonmalignant hepatocytes and breast epithelial cells showed no change in proliferation when exposed to these frequencies.
  • Inhibition of HCC cell proliferation correlated with downregulation of XCL2 and PLP2 and disruption of the mitotic spindle.

Conclusions:

  • A novel mechanism for controlling cancer cell growth using specific modulation frequencies has been identified.
  • This approach demonstrates selective anti-cancer effects without impacting normal tissues.
  • These findings hold significant potential for developing new oncology treatments.